BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2846872)

  • 1. Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro.
    Nicklin MJ; Harris KS; Pallai PV; Wimmer E
    J Virol; 1988 Dec; 62(12):4586-93. PubMed ID: 2846872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of enzymatically active poliovirus proteinase 3C produced in Escherichia coli.
    Takahara Y; Ando N; Kohara M; Hagino-Yamagishi K; Nomoto A; Itoh H; Numao N; Kondo K
    Gene; 1989 Jul; 79(2):249-58. PubMed ID: 2551776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.
    Harris KS; Reddigari SR; Nicklin MJ; Hämmerle T; Wimmer E
    J Virol; 1992 Dec; 66(12):7481-9. PubMed ID: 1331532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases.
    Nicklin MJ; Kräusslich HG; Toyoda H; Dunn JJ; Wimmer E
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4002-6. PubMed ID: 3035560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.
    Hall DJ; Palmenberg AC
    Virus Genes; 1996; 13(2):99-110. PubMed ID: 8972564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of synthetic peptides by purified poliovirus 3C proteinase.
    Pallai PV; Burkhardt F; Skoog M; Schreiner K; Bax P; Cohen KA; Hansen G; Palladino DE; Harris KS; Nicklin MJ
    J Biol Chem; 1989 Jun; 264(17):9738-41. PubMed ID: 2542331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple purification and fluorescent assay method of the poliovirus 3C protease searching for specific inhibitors.
    Hata S; Sato T; Sorimachi H; Ishiura S; Suzuki K
    J Virol Methods; 2000 Feb; 84(2):117-26. PubMed ID: 10680961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
    Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro.
    Jore J; De Geus B; Jackson RJ; Pouwels PH; Enger-Valk BE
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1627-36. PubMed ID: 2839599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the poliovirus 3CD proteinase S1-specificity pocket affect substrate recognition and RNA binding.
    Blair WS; Nguyen JH; Parsley TB; Semler BL
    Virology; 1996 Apr; 218(1):1-13. PubMed ID: 8615011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification, properties, and mutagenesis of poliovirus 3C protease.
    Baum EZ; Bebernitz GA; Palant O; Mueller T; Plotch SJ
    Virology; 1991 Nov; 185(1):140-50. PubMed ID: 1656583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the proposed FG loop of poliovirus proteinase 3C identifies amino acids that are necessary for 3CD cleavage and might be determinants of a function distinct from proteolytic activity.
    Hämmerle T; Molla A; Wimmer E
    J Virol; 1992 Oct; 66(10):6028-34. PubMed ID: 1326654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage specificity of the poliovirus 3C protease is not restricted to Gln-Gly at the 3C/3D junction.
    Kean KM; Teterina N; Girard M
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2553-63. PubMed ID: 2174954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant poliovirus 3C protease. The enzyme application to protein specific fragmentation.
    Sablina EP; Antonov VK
    FEBS Lett; 1991 Jun; 283(2):291-4. PubMed ID: 1646125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of recombinant hepatitis A virus 3C proteinase.
    Malcolm BA; Chin SM; Jewell DA; Stratton-Thomas JR; Thudium KB; Ralston R; Rosenberg S
    Biochemistry; 1992 Apr; 31(13):3358-63. PubMed ID: 1313294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates.
    Schultheiss T; Sommergruber W; Kusov Y; Gauss-Müller V
    J Virol; 1995 Mar; 69(3):1727-33. PubMed ID: 7853510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase.
    Ypma-Wong MF; Semler BL
    Nucleic Acids Res; 1987 Mar; 15(5):2069-88. PubMed ID: 3031587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.